Gelatin has been the excipient of choice of the pharmaceutical industries for years. With increasing demand for clean label products being sourced by nature, the high importance of operational effectiveness, and stringent regulatory pressures, gelatin is the future-proof excipient to meet today and tomorrows’ pharmaceutical industry challenges. As the global leader in gelatin, Rousselot is willing to continue to lead the way in bringing world-class gelatin and support, as well as innovation to its customers. Joining IPEC is part of its mission to always “reach further” with its customers.
The IPEC membership will provide Rousselot with the opportunity to contribute to the development of future quality guidelines and regulatory standards for the use of gelatin in pharmaceutical excipients, and it will give Rousselot access to a unique network of international experts with the same interests and goals.
Joel D’Silva, Director Global Regulatory Affairs, Rousselot comments: “We are very enthusiastic about the opportunities that our representation in the IPEC committee opens up. Compliance and regulatory foresight is essential for our operations, as our worldwide teams continue to keep abreast of both local and global environments. Through our IPEC Europe membership, we see an opportunity to be kept informed of future quality standards and regulatory developments as well as increase our collaboration with the excipient community. This will also enable us to better meet the needs of our customers and ensure we continue to offer safe, efficient and proven gelatin products and services to the pharmaceutical industry.”
1 Global Industry Analysts, Inc., Gelatin, A Global Strategic Business report, Nov 2016